Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Jul 13, 2021 9:50am
37 Views
Post# 33535241

RE:its simple they gave way plasma division and cancelled 4050

RE:its simple they gave way plasma division and cancelled 4050Edrose, it appears that they are trying to position the company as worthless without any goals/ milestones. Do you think that thomvest is purposely burying 4050 and 4547 to take private in some numbered Cayman Islands company that would sell to big pharma that was at negotiating table in 2018? 

edrose wrote: research  when they said they would invest money and efforts in dev small molecules

basically nothing left in this company  that was worth few billion few years ago 


<< Previous
Bullboard Posts
Next >>